Sera from patients with annular erythema (AE) of Sjogren's syndrome (SS) and subacute cutaneous lupus erythematosus (SCLE) have lower RoSS-A autoantibody titers than are typically found in sera from Sjogren's syndrome patients that do not have AE

1994 ◽  
Vol 8 (1) ◽  
pp. 86
Author(s):  
D.P. McCauliffe ◽  
T. Hashimoto ◽  
Y. Hoshino ◽  
T. Nishikawa
1997 ◽  
Vol 36 (2) ◽  
pp. 214-218 ◽  
Author(s):  
Takahiro Watanabe ◽  
Tetsuya Tsuchida ◽  
Yuriko Ito ◽  
Naoko Kanda ◽  
Yoshitsugu Ueda ◽  
...  

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 1790.1-1791
Author(s):  
M. Kaleda ◽  
I. Nikishina

Background:Systemic lupus erythematosus with juvenile onset (jSLE) with Sjogren’s syndrome (SS) in children is a poorly studied and rare combination, the frequency of which, according to the literature, is 7.5-10.0%1.Objectives:To study demographic data, specific features of jSLE with SS in single center.Methods:Retrospective study of all consequently patients (pts) of single-center in pediatric department with combination of jSLE and SS.Results:SS was verified in 14 pts with jSLE (14.3% were boys), which amounted to 15.5% of all pts with jSLE. The median age of jSLE onset was 13.5 y.o. [9.3; 14.9]. The median of disease duration at the time of SS verification was 1.3 y [0.6; 2.9]. Expressed constitutional disorders (fever, weight loss) observed in 13 pts (91.7%). 11 pts (78.6%) had acute cutaneous lupus, 5 pts (35.7%) – chronic cutaneous lupus, 3 (21.4%) – oral and nasal ulcers, 6 (42.8%) – nonscarring alopecia, 9 pts (64.3%) – polyarthritis, 2 pts (14.3%) – renal involvement, 2 pts (14.3%) – serositis, 1 (7.1%) – interstitial lung disease, 5 pts (35.7%) – neuropsychiatric disorder, including psychosis in 2 (14.3%). 4 patients had skin lesions atypical for SLE (1 - annular erythema, 1 - erythema nodosum, 2 - Ro-associated skin vasculitis). 12 pts (85.7%) had generalized lymphadenopathy.12 pts (85.7%) had various hematological disorders: anemia – in 5 pts (35.7%), leukopenia – in 9 (64.3%), isolated lymphopenia in 1 (7.1%), thrombocytopenia – in 4 pts (28.6%). 13 pts had isolated involvement of salivary glands, 1 – combined with lacrimal glands. The decrease in salivary gland function was recorded in 50% of cases, hypolacrimia – in one case. Recurrent parotitis was present in only one case (7.1%). ANA were detected in 100% pts, anti-dsDNA – in 10 pts (71.4%), anti-Sm – in 7 pts (50.0%), anti-Ro - in 10 (71.4%), anti-La - in 7 (50%), RNP-70 – in 5 pts (35.7%), RF+ - in 6 pts (42.9%), hypocomplementemia – in 3 pts (21.4%). The most common was the combination of positive ANA, anti-dsDNA, antiRo with acute cutaneous lupus, polyarthritis, generalized lymphadenopathy and expressed constitutional disorders – 8 pts (57.1%). 4 pts (28.6%) had polyclonal hypergammaglobulinemia. 3 pts (21.4%) had concomitant autoimmune non-rheumatic disease; 1 - autoimmune hepatitis, 1 - type 1 diabetes mellitus, 1 - autoimmune thyroiditis. Median disease activity by SLEDAI at the time of jSLE verification was 11.5 scores [9.25;15.7].Conclusion:According to our results, the frequency of detection of secondary SS in jSLE was higher than the literature data. The clinical features include a high frequency of constitutional disorders, lymphadenopathy, skin manifestations, high frequency of antiRo with a significantly lower incidence of kidney involvement, serositis than jSLE without SS. In pts with a diagnosis of SLE, the possibility of developing secondary SS should be considered (specially in girls with antiRo positive), the early detection of which affects the choice of therapy and prognosis.References:[1]Malagón C, Gomez M, Mosquera C et al. Juvenile polyautoimmunity in a rheumatology setting. Autoimmunity Reviews, Volume 18, Issue 4, 2019, p 369-381.https://doi.org/10.1016/j.autrev.2018.11.006.Disclosure of Interests:None declared


2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 1600.1-1601
Author(s):  
R. Shayakhmetova ◽  
L. P. Ananyeva ◽  
O. Koneva ◽  
M. Starovoytova ◽  
O. Ovsyannikova ◽  
...  

Background:Patients with systemic sclerosis positive for anti-U1RNP have special clinical picture and disease progression. The autoimmune profile in this group is poorly understood.Objectives:The purpose of our work was to study the level of major autoantibodies in patients with systemic sclerosis positive for anti-U1RNP.Methods:The study included 80 patients (71 women and 9 men, mean age 44,5±14 years) positive for antibodies to RNP and meeting the criteria of the systemic sclerosis (ACR/EULAR 2013). Patients were examined for autoantibodies: RF, ACCP, ACA, anti-Scl70, anti-RNAP-III, anti-Ro, anti-La, anti-dsDNA, anti-Sm, ACL, anti-Jo1. 44 patients were examined in dynamics in 24 months.Results:In the study group the clinical picture was dominated by inflammatory musculoskeletal lesions (synovitis and myopathy), skin manifestations were poorly expressed. Interstitial lung disease was detected in 68% of cases. Overlaps (34%) with other rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus) and combination with Sjogren’s syndrome (32.5%) were frequently noted. Other antibodies were often detected: commonly - RF (31%), anti-Ro (38%), anti-dsDNA (42%), rarely - anti-Sm (11%), ACCP (8%), anti-La (8%), ACA (6%), anti-Scl70 (6%), AKL (2%). Anti-Jo1 and anti-RNAP-III were not detected at all. In patients with systemic sclerosis highly-positive for anti-U1RNP (more than 2 upper normal limits) RF, anti-Ro, anti-dsDNA were significantly more common in comparison with low-positive(p=0.00). In dynamics 80% of patients maintained anti-U1RNP, while other autoantibodies were detected with the same frequency. In patients with initially low titer of anti-U1RNP, their disappearance was noted.Conclusion:Patients with systemic sclerosis positive for anti-U1RNP differ in the predominance of inflammatory musculoskeletal manifestations and frequent combination with Sjogren’s syndrome and overlaps. Highly positivity for anti-U1RNP is accompanied by a persistent increase in RF, anti-Ro, anti-dsDNADisclosure of Interests:None declared


Sign in / Sign up

Export Citation Format

Share Document